| [1] |
Sakamoto E, Nimura Y, Hayakawa N, et al. Clinicopathological studies of mucin-producing cholangiocarcinoma[J]. J Hepato Biliary Pancreat Surg, 1997, 4(2):157-162.
|
| [2] |
Ohtsuka M, Shimizu H, Kato A, et al. Intraductal papillary neoplasms of the bile duct[J]. Int J Hepatol, 2014:459091.
|
| [3] |
Gordon-Weeks AN, Jones K, Harriss E, et al. Systematic review and meta-analysis of current experience in treating IPNB: clinical and pathological correlates[J]. Ann Surg, 2016, 263(4):656-663.
|
| [4] |
Zen Y, Fujii T, Itatsu K, et al. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas[J]. Hepatology, 2006, 44(5):1333-1343.
|
| [5] |
Zaccari P, Cardinale V, Severi C, et al. Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas[J]. World J Gastroenterol, 2019, 25(31):4343-4359.
|
| [6] |
Luvira V, Pugkhem A, Bhudhisawasdi V, et al. Long-term outcome of surgical resection for intraductal papillary neoplasm of the bile duct[J]. J Gastroenterol Hepatol, 2017, 32(2):527-533.
|
| [7] |
Zen Y, Jang KT, Ahn S, et al. Intraductal papillary neoplasms and mucinous cystic neoplasms of the hepatobiliary system: demographic differences between Asian and Western populations, and comparison with pancreatic counterparts[J]. Histopathology, 2014, 65(2):164-173.
|
| [8] |
Wan XS, Xu YY, Qian JY, et al. Intraductal papillary neoplasm of the bile duct[J]. World J Gastroenterol, 2013, 19(46):8595-8604.
|
| [9] |
Nakanuma Y, Uesaka K, Kakuda Y, et al. Intraductal papillary neoplasm of bile duct:updated clinicopathological characteristics and molecular and genetic alterations[J]. J Clin Med, 2020, 9(12):3991.
|
| [10] |
Jang KT, Hong SM, Lee KT, et al. Intraductal papillary neoplasm of the bile duct associated with Clonorchis sinensis infection[J]. Virchows Arch, 2008, 453(6):589-598.
|
| [11] |
Kubo S, Nakanuma Y, Takemura S, et al. Case series of 17 patients with cholangiocarcinoma among young adult workers of a printing company in Japan[J]. J Hepatobiliary Pancreat Sci, 2014, 21(7):479-488.
|
| [12] |
Rocha FG, Lee H, Katabi N, et al. Intraductal papillary neoplasm of the bile duct:a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?[J]. Hepatology, 2012, 56(4):1352-1360.
|
| [13] |
Han SY, Kim DU, Nam HS, et al. Comparison of the malignant predictors in intrahepatic and extrahepatic intraductal papillary neoplasm of the bile duct[J]. J Clin Med, 2022, 11(7):1985.
|
| [14] |
Yoon HJ, Kim YK, Jang KT, et al. Intraductal papillary neoplasm of the bile ducts:description of MRI and added value of diffusion-weighted MRI[J]. Abdom Imaging, 2013, 38(5):1082-1090.
|
| [15] |
Sakai, Ohtsuka M, Sugiyama H, et al. Current status of diagnosis and therapy for intraductal papillary neoplasm of the bile duct[J]. World J Gastroenterol, 2021, 27(15):1569-1577.
|
| [16] |
Miyata T, Uesaka K, Nakanuma Y. Cystic and papillary neoplasm at the hepatic hilum possibly originating in the peribiliary glands[J]. Case Rep Pathol, 2016, 2016:9130754.
|
| [17] |
Pehlivanoglu B, Adsay V. Intraductal tubulopapillary neoplasmsof the bile ducts:identity, clinicopathologic characteristics, and differential diagnosis of a distinct entity among intraductal tumors[J]. Hum Pathol, 2023(132):12-19.
|
| [18] |
Adsay V, Jang KT, Roa JC, et al. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases[J]. Am J Surg Pathol, 2012, 36(9):1279-1301.
|
| [19] |
吴昕, 李秉璐, 郑朝纪, 等. 胆管导管内乳头状肿瘤的临床病理特征与治疗策略[J]. 中华消化外科杂志, 2021, 20(8):876-882.
|
| [20] |
Nakanuma Y, Uesaka K, Miyayama S, et al. Intraductal neoplasms of the bile duct. a new challenge to biliary tract tumor pathology[J]. Histol Histopathol, 2017, 32(10):1001-1015.
|
| [21] |
Onoe S, Ebata T, Yokoyama Y, et al. A clinicopathological reappraisal of intraductal papillary neoplasm of the bile duct (IPNB):a continuous spectrum with papillary cholangiocarcinoma in181 curatively resected cases[J]. HPB, 2021, 23(10):1525-1532.
|
| [22] |
Ohtsuka M, Kimura F, Shimizu H, et al. Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion[J]. Am J Surg Pathol, 2011, 35(4):512-521.
|
| [23] |
Tomita H, Tanaka K, Hirata A, et al. Inhibition of FGF10-ERK signal activation suppresses intraductal papillary neoplasm of the bile duct and its associated carcinomas[J]. Cell Rep, 2021, 34(8):108772.
|
| [24] |
Goeppert B, Stichel D, Toth R, et al. Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis[J]. Gut, 2022, 71(2):391-401.
|
| [25] |
Sasaki M, Matsubara T, Nitta T, et al. GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct[J]. PLoS One, 2013, 8(12):e81706.
|
| [26] |
Date K, Ohtsuka T, Fujimoto T, et al. GNAS and KRAS mutational analyses of intraductal papillary neoplasms of the pancreas and bile duct developing in the same individual:a case report[J]. Pancreatology, 2015, 15(6):713-716.
|
| [27] |
Tsai JH, Liau JY, Yuan CT, et al. RNF43 mutation frequently occurs with GNAS mutation and mucin hypersecretion in intraductal papillary neoplasms of the bile duct[J]. Histopathology, 2017, 70(5):756-765.
|
| [28] |
郭伟, 张忠涛. 胆管内乳头状肿瘤的诊断与治疗[J]. 中华消化外科杂志, 2018, 17(3):233-236.
|
| [29] |
Krawczyk M, Ziarkiewicz-Wróblewska B, Podgórska J, et al. Intraductal papillary neoplasm of the bile duct-a comprehensive review[J]. Adv Med Sci, 2021, 66(1):138-147.
|
| [30] |
蔡慧强, 耿智敏. 胆管内乳头状肿瘤的研究进展[J]. 中华消化外科杂志, 2017, 16(8):879-882.
|
| [31] |
Hu LH, Liu MH, Liao Z, et al. Continuous infusion of N-acetylcysteine by nasobiliary for advanced intraductal papillary mucinous neoplasm of bile ducts (with video)[J]. Am J Gastroenterol, 2012, 107(12):1929-1930.
|